The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim safety and efficacy data of [212Pb]VMT01 in MC1R expressing melanoma.
 
Zachary Morris
Research Funding - Perspective Therapeutics/Viewpoint Molecular Targeting (Inst)
 
Richard Wahl
Stock and Other Ownership Interests - Clarity Pharmaceuticals
Honoraria - Abdera Thereapeutics; Bristol-Myers Squibb; Jubilant DraxImage; Molecular Targeting Technologies; perspective therapeutics; Radiopharm Theranostics; Seno Medical; Siemens Healthineers; Voximetry
Consulting or Advisory Role - clarity pharmaceuticals
Research Funding - Actinium Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Fusion Pharmaceuticals (Inst); perspective/viewpoint pharmaceuticals (Inst); RayzeBio (Inst); Siemens Healthineers (Inst); white rabbit AI (Inst)
Travel, Accommodations, Expenses - Actinium Pharmaceuticals; Siemens Healthineers; Viewpoint Molecular Targeting
Other Relationship - society of nuclear medicine
 
Matthew Block
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Marker, Inc. (Inst); Merck (Inst); nference (Inst); Perspective Therapeutics (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst); TILT Biotherapeutics (Inst); Transgene (Inst); Viewpoint Molecular Targeting (Inst)
Patents, Royalties, Other Intellectual Property - Combinations of Dendritic Cell-Based Vaccines and Checkpoint Inhibitors, patent pending (Inst); Dendritic Cell-Based Vaccines and Uses Thereof, patent pending (Inst)
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting
 
Sam Mehr
Consulting or Advisory Role - Blue Earth Therapeutics; Cellectar
Speakers' Bureau - Bayer
 
Lucia Baratto
Employment - Perspective Therapeutics/Viewpoint Molecular Targeting
 
Ian Marsh
Employment - Perspective Therapeutics/Viewpoint Molecular Targeting
 
Haley Tomash
Employment - Perspective Therapeutics/Viewpoint Molecular Targeting
 
Wenjing Yang
Employment - Perspective Therapeutics/Viewpoint Molecular Targeting
 
Stephen Keefe
Employment - Perspective Therapeutics/Viewpoint Molecular Targeting
 
Markus Puhlmann
Employment - Perspective Therapeutics/Viewpoint Molecular Targeting
 
Yusuf Menda
Research Funding - Fusion Pharmaceuticals (Inst); Novartis Biociencias (Inst); Perspective Therapeutics/Viewpoint Molecular Targeting (Inst)